Variant report
Variant | rs10491567 |
---|---|
Chromosome Location | chr9:21510160-21510161 |
allele | G/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:21466000-21527600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr9:21494800-21527600 | Weak transcription | Gastric | stomach |
3 | chr9:21504800-21510200 | Enhancers | HMEC | breast |
4 | chr9:21505000-21510200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr9:21505200-21510200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr9:21507200-21516800 | Weak transcription | Small Intestine | intestine |
7 | chr9:21507200-21551400 | Weak transcription | H9 Cell Line | embryonic stem cell |
8 | chr9:21507400-21527200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
9 | chr9:21508000-21511600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr9:21508000-21511600 | Weak transcription | HSMM | muscle |
11 | chr9:21508000-21542000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr9:21508200-21511400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
13 | chr9:21508200-21511600 | Weak transcription | NHLF | lung |
14 | chr9:21508200-21511800 | Weak transcription | Placenta | Placenta |
15 | chr9:21508200-21523200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr9:21508200-21527600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
17 | chr9:21508200-21527600 | Weak transcription | Fetal Intestine Small | intestine |
18 | chr9:21508400-21512000 | Genic enhancers | A549 | lung |
19 | chr9:21508600-21517600 | Weak transcription | Fetal Intestine Large | intestine |
20 | chr9:21508800-21510200 | Weak transcription | Placenta Amnion | Placenta Amnion |
21 | chr9:21509000-21510800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
22 | chr9:21509000-21511000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
23 | chr9:21509000-21511600 | Weak transcription | Duodenum Mucosa | Duodenum |
24 | chr9:21509200-21510400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
25 | chr9:21509400-21510200 | Weak transcription | NH-A | brain |
26 | chr9:21509400-21511000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
27 | chr9:21509400-21511200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
28 | chr9:21509400-21511800 | Weak transcription | HUVEC | blood vessel |
29 | chr9:21509400-21514200 | Genic enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
30 | chr9:21509400-21514600 | Weak transcription | NHDF-Ad | bronchial |
31 | chr9:21509800-21510400 | Strong transcription | Osteobl | bone |
32 | chr9:21509800-21514400 | Genic enhancers | NHEK | skin |
33 | chr9:21510000-21514400 | Strong transcription | Hela-S3 | cervix |